From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.

The study, titled “Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tvardi Therapeutics, Inc. ("Tvardi" or "the Company") for ...

Treatment of FHV-1 ocular disease is challenging; until now, it has been treated less successfully with a pill, but it had to be forced on cats, and they didn’t like it.

– After 14 days of treatment in healthy volunteers, ARV-102 decreased lysosomal and neuroinflammatory microglial pathway biomarkers known to be elevated in Parkinson’s disease – NEW HAVEN, Conn., Oct.